Cost-Utility Analysis of Deferiprone for the Treatment of [beta]-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective.
Bentley, Anthony 1; Gillard, Samantha 1; Spino, Michael 2,3; Connelly, John 2; Tricta, Fernando 2
[Article] Pharmacoeconomics. 31(9):807-822, September 2013.

(Format: HTML, PDF)